Philippines revokes Sanofi’s product license for dengue vaccine – Reuters

MANILA (Reuters) – The Philippines has permanently halted the sale, distribution and marketing of Sanofi’s dengue vaccine in the country after the French drug maker failed to meet the directives of regulators. FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau Food and Drug Administration (FDA) Director General Nela Charade Puno said on Tuesday registration certificates for Dengvaxia products have been revoked because of Sanofi’s “brazen defiance” of the agency’s directives. The FDA said Sanofi failed to comply with post marketing authorization requirements as of ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 4

Ähnlich Nachrichten